Abel Hall LLC Has $530,000 Holdings in Sanofi (NASDAQ:SNY)

Abel Hall LLC boosted its stake in Sanofi (NASDAQ:SNY) by 1.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,990 shares of the company’s stock after acquiring an additional 194 shares during the quarter. Abel Hall LLC’s holdings in Sanofi were worth $530,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP boosted its position in Sanofi by 0.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 318,760 shares of the company’s stock worth $15,466,000 after acquiring an additional 1,238 shares during the last quarter. AQR Capital Management LLC bought a new stake in shares of Sanofi in the second quarter worth $344,000. The Manufacturers Life Insurance Company boosted its holdings in Sanofi by 27.3% during the second quarter. The Manufacturers Life Insurance Company now owns 31,528 shares of the company’s stock worth $1,530,000 after purchasing an additional 6,756 shares during the last quarter. Creative Planning grew its position in Sanofi by 9.2% in the second quarter. Creative Planning now owns 187,035 shares of the company’s stock valued at $9,075,000 after purchasing an additional 15,749 shares in the last quarter. Finally, NewEdge Advisors LLC grew its position in Sanofi by 27.2% in the second quarter. NewEdge Advisors LLC now owns 29,587 shares of the company’s stock valued at $1,436,000 after purchasing an additional 6,330 shares in the last quarter. 14.04% of the stock is owned by institutional investors and hedge funds.

Sanofi Stock Down 1.1 %

NASDAQ:SNY opened at $52.37 on Thursday. Sanofi has a twelve month low of $45.22 and a twelve month high of $58.97. The firm has a market capitalization of $132.92 billion, a price-to-earnings ratio of 26.72, a price-to-earnings-growth ratio of 1.19 and a beta of 0.57. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The stock’s 50 day moving average price is $48.99 and its two-hundred day moving average price is $52.22.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. Equities research analysts expect that Sanofi will post 3.82 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com cut shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.